← Companies
MiniMed Group, Inc.
Data as of Nov 11, 2026
MMED
CIK 2062583Lobbying
$420,000 in reported federal lobbying spend across 7 quarterly filings, most recently Oct 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Health Issues$330K4 filings
- Health Issues +1$90K3 filings
Latest filings, Apr 2026 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Oct 20, 2026 | MINIMED GROUP, INC. for MINIMED GROUP INC. Health Issues Issues related to access to diabetes devices (no specific legislation). | $170,000 |
| Oct 20, 2026 | MEHLMAN CONSULTING, INC. for MINIMED GROUP INC. Health Issues · Medicare/Medicaid Issues related to access and coverage of diabetes care, treatment, and devices. Issues related to Medicare competitive bidding for durable medical equipment
Issues related to access and coverage of diabetes care, treatment, and devices. I | $60,000 |
| Jul 20, 2026 | MINIMED GROUP, INC. for MINIMED GROUP INC. Health Issues Issues related to competitive bidding for diabetes devices: S.4037, Diabetes Act. | $80,000 |
| Jul 20, 2026 | MEHLMAN CONSULTING, INC. for MINIMED GROUP INC. Health Issues · Medicare/Medicaid Issues related to access and coverage of diabetes care, treatment, and devices. Issues related to Medicare competitive bidding for durable medical equipment
Issues related to access and coverage of diabetes care, treatment, and devices. I | $30,000 |
| Jun 16, 2026 | MEHLMAN CONSULTING, INC. for MINIMED GROUP INC. Health Issues · Medicare/Medicaid Issues related to medical device access and coverage.
Issues related to medical device access and coverage. | $0 |
| Apr 20, 2026 | MINIMED GROUP, INC. for MINIMED GROUP INC. Health Issues Issues related to competitive bidding for diabetes devices (no specific legislation). | $80,000 |